510(k) · Cleared
ClearedColor LCD Monitor, Model Radiforce RS210
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Eizo Nanao Corporation · LLZ System, Image Processing, Radiological
Cleared on Mar 3, 2010 after a 189-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 27 later devices descend from it.
- Decided
- Mar 3, 2010
- Review
- 189 days
- Class
- Class II
- Product code
- LLZ
- Recalls
- None
- Predicates
- 0
27 later devices descend from it, 3 citing it directly.
- This deviceK092613 Color LCD Monitor, Model Radiforce RS210Eizo Nanao Corporation · 2010
- Descendant · cites it directly · 11 of its ownK113844 Radiforce RX240Eizo Nanao Corporation · 2012
- Descendant · cites it directly · 8 of its ownK131090 2MP Color LCD Monitor, Radiforce MX215Eizo Corporation · 2013
- Descendant · 2 generations on · 5 of its ownK150106 2MP Color LCD Monitor, RadiForce RS240Eizo Corporation · 2015
- Descendant · cites it directly · 5 of its ownK113240 3.7 MP Color LCD Monitor, Radiforce MX270WEizo Nanao Corporation · 2012
- Descendant · 3 generations on · 4 of its ownK160247 2MP Color LCD Monitor, RadiForce RX250 and RX250-AREizo Corporation · 2016
Showing 5 of 27 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 27 · See all- K113844Radiforce RX240Eizo Nanao Corporation · 2012 · cites it directly11descendants
- K1310902MP Color LCD Monitor, Radiforce MX215Eizo Corporation · 2013 · cites it directly8descendants
- K1501062MP Color LCD Monitor, RadiForce RS240Eizo Corporation · 2015 · 2 generations on5descendants
- K1132403.7 MP Color LCD Monitor, Radiforce MX270WEizo Nanao Corporation · 2012 · cites it directly5descendants
- K1602472MP Color LCD Monitor, RadiForce RX250 and RX250-AREizo Corporation · 2016 · 3 generations on4descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | K092613 | Color LCD Monitor, Model Radiforce RS210 | Eizo Nanao Corporation | 2010 | — |
| +1 | K113844 | Radiforce RX240 | Eizo Nanao Corporation | 2012 | — |
| +1 | K131090 | 2MP Color LCD Monitor, Radiforce MX215 | Eizo Corporation | 2013 | — |
| +2 | K150106 | 2MP Color LCD Monitor, RadiForce RS240 | Eizo Corporation | 2015 | — |
| +1 | K113240 | 3.7 MP Color LCD Monitor, Radiforce MX270W | Eizo Nanao Corporation | 2012 | — |
| +3 | K160247 | 2MP Color LCD Monitor, RadiForce RX250 and RX250-AR | Eizo Corporation | 2016 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2012 | 2 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 2 | 0 |
| 2016 | 1 | 0 |
| 2017 | 1 | 0 |
| 2018 | 1 | 0 |
| 2019 | 2 | 0 |
| 2020 | 2 | 0 |
| 2022 | 3 | 0 |
| 2023 | 7 | 0 |
| 2025 | 2 | 0 |
| 2026 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LLZ device
- #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
FDA’s file for it is a 510(k) statement, which names no predicate.
What descends from it? (27)
See all 273 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K113844 (Eizo Nanao Corporation, 2012) has gone furthest, with 11 descendants of its own.
How does its category compare?
All LLZ devicesLLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.
FDA decisions per year · LLZ
58in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LLZ
173in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LLZ
11in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LLZ
116in 2025
MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 76 | 36 | 20 | 152 |
| 2008 | 94 | 52 | 32 | 154 |
| 2009 | 70 | 62 | 21 | 145 |
| 2010 | 51 | 98 | 17 | 145 |
| 2011 | 106 | 79 | 30 | 454 |
| 2012 | 82 | 87 | 12 | 266 |
| 2013 | 95 | 84 | 64 | 1,130 |
| 2014 | 78 | 89 | 6 | 15,631 |
| 2015 | 64 | 90 | 16 | 211 |
| 2016 | 82 | 90 | 12 | 290 |
| 2017 | 78 | 107 | 5 | 104 |
| 2018 | 104 | 105 | 7 | 72 |
| 2019 | 74 | 107 | 2 | 88 |
| 2020 | 81 | 115 | 6 | 82 |
| 2021 | 83 | 116 | 3 | 70 |
| 2022 | 65 | 137 | 4 | 28 |
| 2023 | 87 | 157 | 8 | 26 |
| 2024 | 62 | 131 | 6 | 42 |
| 2025 | 58 | 173 | 11 | 116 |
| 2026 | 45 | 110 | 14 | — |
What is it indicated for?
RadiForce RS21O is intended to be used in displaying and viewing digital images for diagnosis of X-ray or MRI, etc. by trained medical practitioners. RadiForce RS21O does not support the display of mammography images for diagnosis.
Indications for use as stated in the FDA 510(k) statement.
https://510kreport.com/device/K092613 · printed Nov 5, 2026
Cite this page
510(k) Report. “K092613: Color LCD Monitor, Model Radiforce RS210.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K092613
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026